GENEVA, July 31 -- SHANGHAI JINGXIN BIOMEDICAL CO., LTD. filed a patent application (CN2026/073576) for “USE OF DIMDAZENIL OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF”. With publication no. WO/2026/158261, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/5517
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....